| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10470166 | Journal of Psychosomatic Research | 2005 | 4 Pages |
Abstract
One third of those treated with IFN-α developed MD. The HDRSS before treatment reveals the high- and low-risk patients for developing MD. Psychiatric evaluation should be performed prior to IFN-α treatment.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Stavroula Beratis, Aggeliki Katrivanou, Sophia Georgiou, Alexandra Monastirli, Efstathia Pasmatzi, Philippos Gourzis, Dionysios Tsambaos,